Special Drug Use-results Surveillance for long term administration in adult (18 years and older) of CONCERTA, 18mg/ 27mg/ 36mg Tablets
Not Applicable
- Conditions
- Attention deficit hyperactivity disorder (ADHD)
- Registration Number
- JPRN-UMIN000015900
- Lead Sponsor
- Janssen Pharmaceutical K.K
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
Patients of continuous treatment with CONCERTA Tablets from childhood to adult with ADHD is excluded from the study of the subject
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety(Adverse Drug Reaction) Effectiveness(Clinical Global Impression, CAARS)
- Secondary Outcome Measures
Name Time Method